Showing results (191-200 of 204) with videos related to

Sort By:
Pageof 21
Breast Cancer Research and Treatment|June 30, 2009
Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedureE Montagna, G Viale, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 2016
Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1)K Fujiwara, B J Monk, C Lhommé, et al.
NPJ Breast Cancer|June 9, 2025
Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer preventionG Aurilio, D Serrano, M Lazzeroni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2013
Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort studyA Guerrieri-Gonzaga, M Lazzeroni, E Botteri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breastG Pruneri, M Lazzeroni, V Bagnardi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?M M Regan, O Pagani, B Walley, et al.
Tumori|April 4, 1998
Chemoprevention trial of contralateral breast cancer with fenretinide. Rationale, design, methodology, organization, data management, statistics and accrualG De Palo, T Camerini, E Marubini, et al.
The Journal of Investigative Dermatology|October 22, 2013
Rab11b mediates melanin transfer between donor melanocytes and acceptor keratinocytes via coupled exo/endocytosisAbul K Tarafder, Giulia Bolasco, Maria S Correia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2013
A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT studyA DeCensi, B Bonanni, P Maisonneuve, et al.
Journal of Endocrinological Investigation|August 17, 2023
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitorsS Antonini, R Pedersini, M F Birtolo, et al.
Pageof 21